Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06318065
Status:
RECRUITING
Last Update Posted:
2024-03-22
First Post:
2024-02-25
Brief Title:
Surgical Resection Outcomes in Patients With Brain Metastasis
Sponsor:
National Cheng-Kung University Hospital
Organization:
National Cheng-Kung University Hospital
Study Overview
Official Title:
Prognostic Factors Impacting Surgical Resection Outcomes in Patients With Brain
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
While many studies have investigated the prognostic factors for patients undergoing surgical resection for primary brain tumors decision-making for patients with brain metastasis BM is more complex because of their higher burden of comorbidities compared to those with primary brain tumors In addition although various prognostic indicators have been identified to predict prognosis in several types of cancer such as the neutrophil-to-lymphocyte ratio NLR platelet-to-lymphocyte ratio PLR prognostic nutritional index PNI and systemic immune-inflammation index SII limited studies have yet determined which group of patients would yield beater survival outcome after surgical resection for BM This study aimed to investigate the impact of patient and perioperative characteristics and prognostic indicators on survival outcome of patients undergoing surgical resection of BM
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None